Aurobindo Pharma: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | Value Research

Aurobindo Pharma: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

This is to inform you that the representatives of the Company will be interacting in person with a group of healthcare investors from India / Asia in the Corporate Office of Aurobindo Pharma USA Inc. a wholly owned subsidiary of the Company at 279 Princeton Hightstown Road East Windsor NJ 08520 on September 23 2022 between 11:00 am - 12:00 noon (EST).

Click here to view PDF


Other Categories